Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: A case study of Thailand-Reference-Cited by-同舟云学术

Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: A case study of Thailand

Published:2023-12 Issue:4 Volume:8 Page:1177-1189
ISSN:2468-0427
Container-title:Infectious Disease Modelling
language:en
Short-container-title:Infectious Disease Modelling

Author:

Anupong Suparinthon^ORCID,Chantanasaro Tanakorn,Wilasang Chaiwat,Jitsuk Natcha C.,Sararat Chayanin,Sornbundit Kan^ORCID,Pattanasiri Busara,Wannigama Dhammika Leshan^ORCID,Amarasiri Mohan^ORCID,Chadsuthi Sudarat^ORCID,Modchang Charin^ORCID

Publisher

Elsevier BV

Subject

Applied Mathematics,Infectious Diseases,Health Policy

Reference58 articles.

1. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant;Andrews;New England Journal of Medicine,2022

2. COVID-19 annual update: A narrative review;Biancolella;Human Genomics,2023

3. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus;Bubar;Science,2021

4. Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers;Buckner;Proceedings of the National Academy of Sciences,2021

5. Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness;Chen,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel comparison framework for epidemiological strategies applied to age-based restrictions versus horizontal lockdowns;Infectious Disease Modelling;2024-12

2. Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models;Infectious Disease Modelling;2024-12

3. Comparative Analysis of RT-PCR, RT-LAMP, and Antigen Testing Strategies for Effective COVID-19 Outbreak Control: A Modeling Study;2024-07-15

4. Addressing Disparities in Access to Vaccines in Low- and Middle-Income Countries;Advances in Logistics, Operations, and Management Science;2024-04-26

5. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial;eClinicalMedicine;2024-04